ParkinsonsDiseaseHelp

Research & Clinical Trials

Parkinson’s Risk From Living Near Farms: How Studies Account for Other Exposures

See how farm drift studies measure spray records, adjust for smoking and head injury, and test mixtures.

Paraquat and Parkinson’s: What an Animal Study Can Tell Us About Human Risk

Learn what the gut-to-brain rat findings mean for farm exposure and steps that lower risk.

Parkinson’s Pesticide Studies: How Researchers Estimate Exposure Decades Later

Learn how address histories and work tasks translate into Parkinson's pesticide risk estimates.

Paraquat and Parkinson’s Disease: Why Different Studies Reach Different Conclusions

See why paraquat studies disagree and what applicators, neighbors, and caregivers can do to cut exposure risk.

Parkinson’s Brain Changes Before Motor Symptoms: What a New Two-Macaque Study Can Tell Us

Learn which brain signals faded before movement changed and what early signs to track with your doctor.

Parkinson’s Clinical Trial Listings: Read Phase, Location, and Eligibility

Learn how to check a Parkinson's trial's phase, local enrollment status, and screening requirements.

How to Read a Parkinson’s Breakthrough Headline

Most Parkinson's “breakthrough” headlines describe a result in mice, a trial of forty people, or a company press release. None of those are worthless,...

Parkinson’s Research: What Current Evidence Actually Supports

See which Parkinson's treatments help now, which approaches fell short, and what emerging research can—and cannot—show.

Parkinson’s Disease News: What Current Evidence Actually Supports

Learn which Parkinson's advances are available now, which remain experimental, and what trial results mean for daily care.

Early Signs of Parkinson’s Research Review: Findings, Gaps, and Practical Context

Learn which early Parkinson's signs merit evaluation, what biomarkers reveal, and where prediction still falls short.

Personalized stem cell treatment for Parkinson’s: New research shows promising clinical results

See what 12-month trial data reveal about personalized stem cell therapy for Parkinson's—and the limits behind the promising numbers.

SB-0110 Shows Promise in Parkinson’s Research With Innovative PKA Targeting Approach

A clear look at SB-0110's animal results, how it targets PKA-II, and why patients still face a years-long wait.

Parkinson’s Treatment Search Guide: Questions People Are Asking and Clear Answers

People newly diagnosed with Parkinson's ask about cures, medication options, and which approaches actually work—here's what the evidence and clinical experience show.

Traffic Noise May Increase Parkinson’s Disease Risk, New Study Suggests

A major Danish cohort links long-term road noise with a small rise in Parkinson's risk and highlights the value of a quiet-side bedroom.

Personalized stem cell treatment for Parkinson’s: New research shows promising clinical results

Personalized stem cell therapies for Parkinson's show measurable clinical improvements in early trials, but remain experimental and inaccessible to most patients.

SB-0110 Shows Promise in Parkinson’s Research With Innovative PKA Targeting Approach

Researchers are exploring whether blocking a specific cellular protein called PKA could slow Parkinson's disease progression, representing a shift toward disease-modifying therapies.

Alzheimer’s and Parkinson’s research gets $5M boost from major foundations

Foundation funding accelerates discovery timelines and attracts researchers to neurodegenerative disease, though breakthroughs typically take years to reach patients.

Customized Stem Cell Regeneration Therapy Shows Promising Results for Parkinson’s Disease

Stem cell therapies aim to repair Parkinson's damage by generating replacement dopamine neurons, with early research showing encouraging but limited results.

Supine Hypertension Linked to Parkinson’s Orthostatic Hypotension: Clinical Connection

Parkinson's disease can cause a dangerous blood pressure paradox: high pressure while lying down and dangerously low pressure when standing.

Parkinson’s Research Trials: Disease Modification Now Outpaces Symptom Relief Approach

Disease-modifying therapies now drive Parkinson's research, targeting neurodegeneration itself rather than just managing movement symptoms.

« Prev 1 2 3 Next »

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.